Calcium chloride
Identification
- Name
- Calcium chloride
- Accession Number
- DB01164
- Description
Calcium chloride is an ionic compound of calcium and chlorine. It is highly soluble in water and it is deliquescent. It is a salt that is solid at room temperature, and it behaves as a typical ionic halide. It has several common applications such as brine for refrigeration plants, ice and dust control on roads, and in cement. It can be produced directly from limestone, but large amounts are also produced as a by-product of the Solvay process. Because of its hygroscopic nature, it must be kept in tightly-sealed containers.
- Type
- Small Molecule
- Groups
- Approved
- Structure
Structure for Calcium chloride (DB01164)
- Weight
- Average: 110.984
Monoisotopic: 109.900296569 - Chemical Formula
- CaCl2
- Synonyms
- Calcio cloruro
- Calcium chloride anhydrous
- Calcium chloride, anhydrous
- calcium(2+) chloride
- External IDs
- E-509
- INS NO.509
- INS-509
Pharmacology
- Indication
For the treatment of hypocalcemia in those conditions requiring a prompt increase in blood plasma calcium levels, for the treatment of magnesium intoxication due to overdosage of magnesium sulfate, and used to combat the deleterious effects of hyperkalemia as measured by electrocardiographic (ECG), pending correction of the increased potassium level in the extracellular fluid.
- Associated Conditions
- Associated Therapies
- Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More- Pharmacodynamics
Calcium is the fifth most abundant element in the body and the major fraction is in the bony structure. Calcium plays important physiological roles, many of which are poorly understood. It is essential for the functional integrity of the nervous and muscular systems. It is necessary for normal cardiac function and is one of the factors that operates in the mechanisms involved in the coagulation of blood.
- Mechanism of action
Calcium chloride in water dissociates to provide calcium (Ca2+) and chloride (Cl-) ions. They are normal constituents of the body fluids and are dependent on various physiological mechanisms for maintenance of balance between intake and output. For hyperkalemia, the influx of calcium helps restore the normal gradient between threshold potential and resting membrane potential.
Target Actions Organism UProtein S100-A13 Not Available Humans - Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
Approximately 80% of body calcium is excreted in the feces as insoluble salts; urinary excretion accounts for the remaining 20%.
- Route of elimination
Approximately 80% of body calcium is excreted in the feces as insoluble salts; urinary excretion accounts for the remaining 20%.
- Half-life
- Not Available
- Clearance
- Not Available
- Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More- Toxicity
Too rapid injection may produce lowering of blood pressure and cardiac syncope. Persistent hypercalcemia from overdosage of calcium is unlikely because of rapid excretion.
- Affected organisms
- Humans and other mammals
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Unlock Additional DataAbciximab The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Abciximab. Acebutolol The therapeutic efficacy of Acebutolol can be decreased when used in combination with Calcium chloride. Acenocoumarol The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Acenocoumarol. Acetyldigitoxin Calcium chloride may increase the arrhythmogenic and cardiotoxic activities of Acetyldigitoxin. Acetylsalicylic acid The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Acetylsalicylic acid. Alendronic acid The serum concentration of Alendronic acid can be decreased when it is combined with Calcium chloride. Alfacalcidol The risk or severity of adverse effects can be increased when Calcium chloride is combined with Alfacalcidol. Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Calcium chloride. Alteplase The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Alteplase. Aminocaproic acid The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Calcium chloride. Additional Data Available- Extended DescriptionExtended Description
Extended description of the mechanism of action and particular properties of each drug interaction.
Learn more - Severity
- Evidence Level
- ActionAction
An effect category for each drug interaction. Know how this interaction affects the subject drug.
Learn more
- Food Interactions
- No interactions found.
Products
- Product Ingredients
Ingredient UNII CAS InChI Key Calcium chloride dihydrate M4I0D6VV5M 10035-04-8 LLSDKQJKOVVTOJ-UHFFFAOYSA-L - Active Moieties
Name Kind UNII CAS InChI Key Calcium unknown SY7Q814VUP 7440-70-2 OYPRJOBELJOOCE-UHFFFAOYSA-N Chloride ion ionic Q32ZN48698 16887-00-6 VEXZGXHMUGYJMC-UHFFFAOYSA-M Calcium cation ionic 2M83C4R6ZB 14127-61-8 BHPQYMZQTOCNFJ-UHFFFAOYSA-N - International/Other Brands
- Jarcal / LiquiCal-D 400
- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Unlock Additional DataCalciject Inj 100mg/ml Liquid Intravenous Omega Laboratories Ltd 1990-12-31 Not applicable Canada 
Calcium Chloride Injection 100 mg/1mL Parenteral Amphastar Pharmaceuticals, Inc. 1990-01-02 2009-12-31 US 
Calcium Chloride Injection, solution 100 mg/1mL Intravenous; Intraventricular General Injectables & Vaccines, Inc. 2010-03-01 Not applicable US Calcium Chloride Injection 100 mg/1mL Intravenous Amneal-Agila, LLC 2013-05-31 2017-12-31 US Calcium Chloride Injection, solution 100 mg/1mL Intravenous Hospira, Inc. 2005-09-14 Not applicable US Calcium Chloride Injection, solution 100 mg/1mL Intravenous AMERICAN REGENT, INC. 2017-07-05 Not applicable US Calcium Chloride Injection, solution 100 mg/1mL Intravenous General Injectables & Vaccines 2010-03-01 2014-02-01 US Calcium Chloride Injection, solution 100 mg/1mL Intravenous General Injectables & Vaccines, Inc 2010-07-01 Not applicable US Calcium Chloride Injection 100 mg/1mL Parenteral Amphastar Pharmaceuticals, Inc. 1973-05-01 2009-12-31 US Calcium Chloride Injection, solution 100 mg/1mL Intravenous; Intraventricular Hospira, Inc. 2006-01-24 Not applicable US Additional Data Available- Application NumberApplication Number
A unique ID assigned by the FDA when a product is submitted for approval by the labeller.
Learn more - Product CodeProduct Code
A governmentally-recognized ID which uniquely identifies the product within its regulatory market.
Learn more
- Generic Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Unlock Additional DataCalcium Chloride Injection, solution 100 mg/1mL Intravenous AMERICAN REGENT, INC. 2018-02-06 Not applicable US Calcium Chloride Injection 100 mg/1mL Intravenous; Intraventricular HF Acquisition Co LLC, DBA HealthFirst 2019-12-09 Not applicable US Calcium Chloride Injection, solution 100 mg/1mL Intravenous Medefil, Inc. 2019-08-22 Not applicable US Calcium Chloride Injection, solution 100 mg/1mL Intravenous Medical Purchasing Solutions, Llc 2019-08-22 Not applicable US Calcium Chloride Injection 100 mg/1mL Intravenous; Intraventricular International Medication Systems, Limited 2018-07-08 Not applicable US Calcium Chloride Injection 100 mg/1mL Intravenous; Intraventricular A-S Medication Solutions 2018-07-08 2019-04-30 US Additional Data Available- Application NumberApplication Number
A unique ID assigned by the FDA when a product is submitted for approval by the labeller.
Learn more - Product CodeProduct Code
A governmentally-recognized ID which uniquely identifies the product within its regulatory market.
Learn more
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image (40 Mmols/l) Potassium Chloride In Lactated Ringer's Injection USP Calcium chloride (20 mg) + Sodium lactate (310 mg) + Potassium chloride (328 mg) + Sodium chloride (600 mg) Solution Intravenous Baxter Laboratories 2002-12-11 2016-07-15 Canada 5% Dextrose In Lactated Ringer's Injection Calcium chloride (20 mg) + Dextrose, unspecified form (5 g) + Sodium lactate (310 mg) + Potassium chloride (30 mg) + Sodium chloride (600 mg) Solution Intravenous B. Braun Medical Inc. 1993-12-31 2012-04-10 Canada Acetate Concentrate R07376 Calcium chloride (6.432 g) + Dextrose, unspecified form (38.5 g) + Magnesium chloride (3.558 g) + Potassium chloride (2.609 g) + Sodium acetate (114.8 g) + Sodium chloride (204.5 g) Liquid Hemodialysis Bdh Inc. 1995-12-31 2000-08-03 Canada Acid Concentrate (r04146) Calcium chloride (9.477 g) + Acetic acid (8.846 g) + Dextrose, unspecified form (60.8 g) + Magnesium chloride (3.744 g) + Sodium chloride (184 g) Liquid Hemodialysis Genpharm Ulc 1997-05-21 2004-07-30 Canada Acid Concentrate (r04938) Calcium chloride (9.476 g) + Acetic acid (8.846 g) + Dextrose, unspecified form (60.77 g) + Magnesium chloride (3.744 g) + Potassium chloride (5.491 g) + Sodium chloride (172.2 g) Liquid Hemodialysis Genpharm Ulc 1987-12-31 2001-08-03 Canada Acid Concentrate (r04968) Calcium chloride (3.384 g) + Acetic acid (8.846 g) + Magnesium chloride (3.744 g) + Potassium chloride (5.491 g) + Sodium chloride (180.8 g) Liquid Hemodialysis Genpharm Ulc 1988-12-31 2004-07-30 Canada Acid Concentrate (r04969) Calcium chloride (3.384 g) + Acetic acid (8.846 g) + Magnesium chloride (3.744 g) + Potassium chloride (2.746 g) + Sodium chloride (180.8 g) Liquid Hemodialysis Genpharm Ulc 1988-12-31 2004-07-30 Canada Acid Concentrate (r04974) Calcium chloride (6.769 g) + Acetic acid (8.846 g) + Magnesium chloride (3.744 g) + Potassium chloride (8.237 g) + Sodium chloride (172.2 g) Liquid Hemodialysis Genpharm Ulc 1988-12-31 2004-07-30 Canada Acid Concentrate (r04975) Calcium chloride (6.769 g) + Acetic acid (8.846 g) + Magnesium chloride (3.744 g) + Potassium chloride (2.746 g) + Sodium chloride (172.2 g) Liquid Hemodialysis Genpharm Ulc 1988-12-31 2004-07-30 Canada Acid Concentrate (r04976) Calcium chloride (6.769 g) + Acetic acid (8.846 g) + Magnesium chloride (3.744 g) + Potassium chloride (5.491 g) + Sodium chloride (172.2 g) Liquid Hemodialysis Genpharm Ulc 1988-12-31 2004-07-30 Canada - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Calcium Chloride Calcium chloride dihydrate (100 mg/1mL) Injection Parenteral Amphastar Pharmaceuticals, Inc. 1973-05-01 2009-12-31 US Calcium Chloride Calcium chloride dihydrate (100 mg/1mL) Injection, solution Intravenous; Intraventricular Cardinal Health 1984-09-17 2019-04-30 US Calcium Chloride Calcium chloride dihydrate (100 mg/1mL) Injection Intravenous; Intraventricular Medical Purchasing Solutions, Llc 1973-05-01 Not applicable US Calcium Chloride Calcium chloride dihydrate (100 mg/1mL) Injection, solution Intravenous Cardinal Health 2011-06-14 2014-02-28 US Calcium Chloride Calcium chloride dihydrate (100 mg/1mL) Injection, solution Intravenous; Intraventricular Hospira, Inc. 2006-01-24 Not applicable US Calcium Chloride Calcium chloride dihydrate (100 mg/1mL) Injection Parenteral Amphastar Pharmaceuticals, Inc. 2000-06-01 2013-01-25 US Calcium Chloride Calcium chloride dihydrate (20 mg/1mL) Injection, solution Intravenous Cantrell Drug Company 2011-03-08 Not applicable US Calcium Chloride Calcium chloride dihydrate (100 mg/1mL) Injection Intravenous Amneal-Agila, LLC 2013-05-31 2017-12-31 US Calcium Chloride Calcium chloride dihydrate (100 mg/1mL) Injection, solution Intravenous AMERICAN REGENT, INC. 2017-07-05 Not applicable US Calcium Chloride Calcium chloride dihydrate (100 mg/1mL) Injection Parenteral Amphastar Pharmaceuticals, Inc. 1990-01-02 2009-12-31 US
Categories
- ATC Codes
- A12AA07 — Calcium chlorideA11GB01 — Ascorbic acid (vit c) and calcium
- A11GB — Ascorbic acid (vitamin C), combinations
- A11G — ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS
- A11 — VITAMINS
- A — ALIMENTARY TRACT AND METABOLISM
- Drug Categories
- Acidifiers
- Acids
- Acids, Noncarboxylic
- Alimentary Tract and Metabolism
- Anions
- Blood and Blood Forming Organs
- Blood Coagulation Factors
- Blood Substitutes and Perfusion Solutions
- Calcium Compounds
- Calcium Salts
- Chlorides
- Chlorine Compounds
- Electrolyte Solutions
- Electrolytes
- Genito Urinary System and Sex Hormones
- Hemodialysis Solution
- I.V. Solution Additives
- Ions
- Mineral Supplements
- Phosphate Binder
- Replacement Preparations
- Supplements
- Urologicals
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of inorganic compounds known as alkaline earth metal chlorides. These are inorganic compounds in which the largest halogen atom is Chlorine, and the heaviest metal atom is a lanthanide.
- Kingdom
- Inorganic compounds
- Super Class
- Mixed metal/non-metal compounds
- Class
- Alkaline earth metal salts
- Sub Class
- Alkaline earth metal chlorides
- Direct Parent
- Alkaline earth metal chlorides
- Alternative Parents
- Inorganic chloride salts / Inorganic calcium salts
- Substituents
- Alkaline earth metal chloride / Inorganic calcium salt / Inorganic chloride salt / Inorganic salt
- Molecular Framework
- Not Available
- External Descriptors
- inorganic chloride, calcium salt (CHEBI:3312)
Chemical Identifiers
- UNII
- OFM21057LP
- CAS number
- 10043-52-4
- InChI Key
- UXVMQQNJUSDDNG-UHFFFAOYSA-L
- InChI
- InChI=1S/Ca.2ClH/h;2*1H/q+2;;/p-2
- IUPAC Name
- calcium dichloride
- SMILES
- [Cl-].[Cl-].[Ca++]
References
- Synthesis Reference
Silvano Grosso, Kenneth E. Nelson, "Method for preparing liquid feed supplements containing calcium chloride." U.S. Patent US3962484, issued August, 1973.
US3962484- General References
- Not Available
- External Links
- KEGG Compound
- C08130
- PubChem Compound
- 5284359
- PubChem Substance
- 46507257
- ChemSpider
- 23237
- 1667640
- ChEBI
- 3312
- ChEMBL
- CHEMBL1200668
- PharmGKB
- PA448729
- RxList
- RxList Drug Page
- Wikipedia
- Calcium_chloride
- AHFS Codes
- 40:34.00* — Hemodialysis Solution
- 40:12.00 — Replacement Preparations
- MSDS
- Download (74.1 KB)
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Active Not Recruiting Treatment Impaired kidney function 1 4 Completed Treatment APD / Continuous ambulatory peritoneal dialysis therapy / Diabetes / ESRD 1 4 Completed Treatment Cesarean Section / Hypotension / Pregnancy / Spinal Anaesthesia 1 4 Completed Treatment Chronic Kidney Disease (CKD) / Peritoneal dialysis therapy 1 4 Completed Treatment Dehydration 1 4 Completed Treatment Fluid Overload / Postoperative Complications 1 4 Completed Treatment Postoperative pain 1 4 Completed Treatment Subarachnoid Hemorrhage 1 4 Not Yet Recruiting Supportive Care Cesarean Section / Parturition / Spinal Anaesthesia 1 4 Recruiting Treatment Cardiopulmonary Bypass / Surgery, Cardiac 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- American Regent
- AstraZeneca Inc.
- Baxter International Inc.
- Cardinal Health
- General Injectables and Vaccines Inc.
- Hospira Inc.
- J T Baker
- Luitpold Pharmaceuticals Inc.
- Physicians Total Care Inc.
- Spectrum Pharmaceuticals
- Dosage Forms
Form Route Strength Injection, solution 257 mg/1L Injection, solution Intravenous 2.5 g/500mL Powder, for solution Intraocular Solution Intraocular Solution Topical Solution Topical 91 mg/ml Solution Intraperitoneal 951 mg/L Solution Intraperitoneal 0.1838 g/L Solution Intraperitoneal 0.2573 g/L Solution Ophthalmic Solution Intraocular; Irrigation 1950 mg Solution 90 mg/ml Solution 5 % Solution Intravenous 0.64 g/100ml Solution Intravenous 0.86 g/100ml Solution Intravenous 3.1 g/L Injection, solution Intravenous 3.1 g/L Solution Irrigation 48 mg/100mL Kit; solution Intraocular Liquid Intravenous Injection, solution, concentrate Intravenous; Parenteral 1 G/10ML Injection, solution, concentrate Intravenous; Parenteral 500 MG/10ML Injection Intravenous 100 mg/1mL Injection Intravenous; Intraventricular 100 mg/1mL Injection Parenteral 100 mg/1mL Injection, solution 10 g/100mL Injection, solution 50 mg/1mL Injection, solution Intravenous 100 mg/1mL Injection, solution Intravenous 20 mg/1mL Injection, solution Intravenous; Intraventricular 100 mg/1mL Solution Intravenous Powder, for solution Hemodialysis Powder Hemodialysis Solution Parenteral 100 mmol/l Solution Intraperitoneal 0.0003 g Solution Intra-arterial Solution 6340 mg/L Solution Intravenous Solution Irrigation Solution Intraperitoneal Solution Intravenous 6.4 g/L Injection Intravenous Injection, solution Intraperitoneal 220 mg Solution Intraperitoneal; Irrigation 18.3 mg Solution Intraperitoneal 18.3 mg Injection, solution Intraperitoneal Liquid Hemodialysis Solution Hemodialysis Injection, solution Intraperitoneal 18.3 mg/100mL Solution 22.7 g/L Solution 13.6 g/L Solution Intraperitoneal 22.7 g/L Solution 38.6 g/L Solution Intraperitoneal 13.6 g/L Solution Intraperitoneal 38.6 g/L Solution Intravenous 4.21 g/1000ml Solution Intrathecal Injection Intrathecal Solution Intraperitoneal 0.0257 g Solution 75 g/L Injection, solution Intraperitoneal 25.7 mg/100mL Solution Intraperitoneal 7.5 g/100mL Solution Intravenous 1.63 g Spray Oral 7.3 mg/50mL Solution, concentrate 9 g/1L Solution, concentrate 6.43 g/1L Solution Oral 30 mg Solution Oral 0.275 g Solution Oral 275 mg Solution Intravenous 3 g Solution Intravenous 0.31 % Solution Intraperitoneal 7.5 % Liquid Intraperitoneal Solution Hemodialysis; Intraperitoneal Solution Intravenous 0.02 g Liquid Intraocular Solution 0.64 g/100ml Solution Intravenous 0.64 % Solution Intravenous 0.07 g Injection, emulsion Intravenous Injection Intravenous 110 g Injection Intravenous 165 g Injection Intravenous 220 g Injection Intravenous 275 g Injection Intravenous 107 g Injection Intravenous 143 g Injection Intravenous 178 g Solution Intravenous 8.6 % Solution Intravenous 20.475 % Injection, solution Intravenous 30 mg/100mL Liquid Irrigation Solution, for slush Irrigation Solution Intravenous 20 mg Solution Intravenous; Irrigation 0.2 mg Injection, solution Intravenous 50 mg/mL Injection, solution Intravenous 3 g/L Injection, solution Intravenous 3.14 g/L Liquid Buccal Spray Buccal Kit; solution Intraocular; Irrigation Solution Intravenous 5 g/100ml Solution Intravenous 0.86 % Solution 16 g/L Emulsion Intravenous 1.83 g Injection Intravenous 1.03 g Injection, emulsion Intravenous 1.6 g/100mL Injection, emulsion; injection, solution Intravenous 3.2 g/100mL Emulsion Intravenous 20 mg Emulsion Intravenous 16 g Injection, solution, concentrate Intravenous Solution Intraperitoneal 510 mg/l Injection, emulsion Intravenous 1.6 g Injection Intravenous 2.27 g/l Injection Intravenous 4.12 g/l Solution Intravenous 7.14 g Solution Intravenous 9.52 g Solution Intravenous 11.9 g Emulsion Intravenous 6.41 g Emulsion Intravenous 9.61 g Emulsion Intravenous 12.82 g Emulsion Intravenous 4 g Solution Intraocular; Ophthalmic 7.8 mg Rinse Dental Injection, solution Intraperitoneal 32 mg/100mL Solution Oral 29.4 mg Solution Oral 100 mg Emulsion Intravenous Emulsion Intravenous 3 g Injection, solution Intravenous 5 % Solution Intraperitoneal 15 g/L Solution Intraperitoneal 25 g/L Solution Intravenous 25 g/L Solution Intraperitoneal 42.5 g/L Injection, solution Intravenous Injection, solution Intra-arterial Solution Solution Intravenous 5 % Solution Intravenous 0.035 % Solution 3.2 g/100mL Solution 1.6 g/100mL Liquid Intravenous Kit Hemodialysis Solution Hemodialysis; Intravenous Injection, solution 514.5 mg/100mL Injection, solution Intravenous 0.86 g/100mL Kit; solution Topical Solution Intravenous 0.6 g/100ml Solution Intravenous 0.31 g/100ml Solution Irrigation; Topical 20 mg Injection, solution Intravenous 20 mg/100mL Injection, solution 20 mg/100mL Irrigant Irrigation Solution Buccal; Oral; Topical 16.2 mg Aerosol Oral Emulsion Parenteral 50 g Solution Intravenous 0.2 mg Solution Intraperitoneal 25.7 mg Solution Intravenous 6 mg Solution Intravenous 33 mg Solution Intraocular; Irrigation 0.39 g Kit Topical Powder Topical 91 mg/ml Solution Topical 3000 kiu Kit; solution 91 mg/mL Solution Intravenous; Irrigation 0.62 g/100ml - Prices
Unit description Cost Unit SureStep Test 25 Strip Box 31.92USD box Calcium chloride powder 0.44USD g Calcium chloride 10% vial 0.18USD ml Calcium chloride granules 0.1USD g Calcium chloride 10% ampul 0.07USD ml DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.- Patents
Patent Number Pediatric Extension Approved Expires (estimated) Region Unlock Additional DataUS6077836 No 2000-06-20 2017-06-20 US US6248726 No 2001-06-19 2018-06-19 US US7084130 No 2006-08-01 2021-11-29 US Additional Data Available- Filed On
Properties
- State
- Solid
- Experimental Properties
Property Value Source melting point (°C) 782 °C Not Available water solubility 0.745 g/mL (at 20 °C) Not Available - Predicted Properties
Property Value Source Water Solubility 21.4 mg/mL ALOGPS logP 1.08 ALOGPS logP -0.57 ChemAxon logS -0.71 ALOGPS pKa (Strongest Acidic) 3.09 ChemAxon Physiological Charge 2 ChemAxon Hydrogen Acceptor Count 0 ChemAxon Hydrogen Donor Count 0 ChemAxon Polar Surface Area 0 Å2 ChemAxon Rotatable Bond Count 0 ChemAxon Refractivity 0 m3·mol-1 ChemAxon Polarizability 1.78 Å3 ChemAxon Number of Rings 0 ChemAxon Bioavailability 1 ChemAxon Rule of Five Yes ChemAxon Ghose Filter No ChemAxon Veber's Rule Yes ChemAxon MDDR-like Rule No ChemAxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9445 Blood Brain Barrier + 0.975 Caco-2 permeable + 0.6764 P-glycoprotein substrate Non-substrate 0.9039 P-glycoprotein inhibitor I Non-inhibitor 0.9891 P-glycoprotein inhibitor II Non-inhibitor 0.9866 Renal organic cation transporter Non-inhibitor 0.9196 CYP450 2C9 substrate Non-substrate 0.8116 CYP450 2D6 substrate Non-substrate 0.717 CYP450 3A4 substrate Non-substrate 0.7571 CYP450 1A2 substrate Non-inhibitor 0.7506 CYP450 2C9 inhibitor Non-inhibitor 0.8587 CYP450 2D6 inhibitor Non-inhibitor 0.9306 CYP450 2C19 inhibitor Non-inhibitor 0.8304 CYP450 3A4 inhibitor Non-inhibitor 0.956 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9002 Ames test Non AMES toxic 0.6808 Carcinogenicity Carcinogens 0.764 Biodegradation Ready biodegradable 0.6815 Rat acute toxicity 1.9786 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9433 hERG inhibition (predictor II) Non-inhibitor 0.9634
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
Targets
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Zinc ion binding
- Specific Function
- Plays a role in the export of proteins that lack a signal peptide and are secreted by an alternative pathway. Binds two calcium ions per subunit. Binds one copper ion. Binding of one copper ion doe...
- Gene Name
- S100A13
- Uniprot ID
- Q99584
- Uniprot Name
- Protein S100-A13
- Molecular Weight
- 11471.095 Da
References
- Sivaraja V, Kumar TK, Rajalingam D, Graziani I, Prudovsky I, Yu C: Copper binding affinity of S100A13, a key component of the FGF-1 nonclassical copper-dependent release complex. Biophys J. 2006 Sep 1;91(5):1832-43. Epub 2006 Jun 9. [PubMed:16766622]
Drug created on June 13, 2005 07:24 / Updated on October 21, 2020 01:55
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
![]({"CS-Molecular-Health-1.jpg":"/assets/ads/CS-Molecular-Health-1-19e76f023997d5ac198da2cb9976457f7b9ba733f0ea8a780fe21191c759e8fa.jpg","Drug-Dev-2.jpg":"/assets/ads/Drug-Dev-2-7c3039d93245f493c23278efbf759e4f933848a676262d579087d5cc516af179.jpg","Drug-Search-3.jpg":"/assets/ads/Drug-Search-3-7346c33d2133f62b46cbfbbe2b666e78f955c6847e242692c6081fec37c4d10d.jpg","PM-3.jpg":"/assets/ads/PM-3-13494ac4c996d71619127a11f685681418d4280832dec162c0b2c9c8bc2eda50.jpg","OD-Webinar-1.jpg":"/assets/ads/OD-Webinar-1-f9357f6d57fef5e411aa1c0439ef46c86d9151214434659d096eeed6407b799b.jpg","DDI-3.jpg":"/assets/ads/DDI-3-12808cf864d540ad43757b10b08fc52ae93e793b0c6e81345555187b2840ad09.jpg","EMR-2.jpg":"/assets/ads/EMR-2-adacf8de3f42cb06d6676d06fce611c29781db6ad30776cd18b72a7d8e69f0c8.jpg","Covid.jpg":"/assets/ads/Covid-eed8f17668b0308db62ce3c656f5e2f562376e9185ae08dda5ce6ed9ab0bbd1f.jpg","CS-Molecular-Health-2.jpg":"/assets/ads/CS-Molecular-Health-2-22f41f94b3f87e44a1dcaa8f6c03dc411ab69558efd4f3148ff9bb6adaa956dc.jpg","PM-5.jpg":"/assets/ads/PM-5-d0dc031e0fa0d0097d912eff07b7e80b27b867264dd5b055e379a57bfa2a8723.jpg","DDI-4.jpg":"/assets/ads/DDI-4-313b9c374b937fd78bb2ade652b9b030abb9e6cb90efd35833f793e384e8185b.jpg","Discover-1.jpg":"/assets/ads/Discover-1-b48ae6a3872eeb442f4c22a9a1d867428c83a917ec78a8c3ff4e02f84c5d4fef.jpg","Discover-2.jpg":"/assets/ads/Discover-2-6e7759998ee0fdc234cd84eea962f2480f0c7dafadabd785924918420decb102.jpg","Repurpose-1.jpg":"/assets/ads/Repurpose-1-265fbec40f0eac18d51d3ec4f558c10cb623d834ea75e0296259e458b72ee6d4.jpg","Repurpose-2.jpg":"/assets/ads/Repurpose-2-d12bd1d18b92d36eab60e71e6fd59acf04ef60a53783570e11eef397a0e0f4f5.jpg","PM-6.jpg":"/assets/ads/PM-6-3ae66e41f7ae1e851a0910be89141cf2533509b46df6379464efc885d5ee2f07.jpg","Drug-Search-4.jpg":"/assets/ads/Drug-Search-4-2a9102bd41f16e8c40c9d8044d1dcb6f206ff80107cc269aa83d02ea683bc829.jpg","DDI-5.jpg":"/assets/ads/DDI-5-fa1c287946f4044094c723161577cb5ac631f9cd1217446e510dc79ace6cb94e.jpg","TH-1.jpg":"/assets/ads/TH-1-55a9077bb39e8c38a68c67b555b8091d21a9d41b1c21c7daed3fe53e6f9f3c97.jpg","TH-2.jpg":"/assets/ads/TH-2-1d488747fa4af00ab970a48dba0b228b054d166aa22c1760a310e2b72dd22589.jpg"})
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates